Skip to content
Trial Eligibility
Menu

Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)

NCT00001248

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Studies performed under 89-N-0045 are designed to examine the natural history of multiple sclerosis (MS) using MRI and immunological measures. In addition to studying the natural history of untreated patients, the natural history of patients receiving approved disease-modifying therapies of MS will be examined. In both cohorts of patients levels of disease activity on MRI will be compared with immunological characteristics in order to help identify disease mechanism.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Multiple Sclerosis

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 120 years
Sex
All
Healthy volunteers
Accepted
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Last updated on ClinicalTrials.gov
September 16, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • National Institutes of Health Clinical Center · Bethesda, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.